Business Description
RP Bio lnc
ISIN : KR7314140005
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 2.44 | |||||
Interest Coverage | 3.35 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.12 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.1 | |||||
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 19 | |||||
3-Year FCF Growth Rate | 49.7 | |||||
3-Year Book Growth Rate | 9.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.73 | |||||
9-Day RSI | 27.96 | |||||
14-Day RSI | 32.55 | |||||
6-1 Month Momentum % | 3.06 | |||||
12-1 Month Momentum % | -17.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 101.06 | |||||
Days Sales Outstanding | 54.04 | |||||
Days Payable | 64.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.58 | |||||
Dividend Payout Ratio | 0.11 | |||||
Forward Dividend Yield % | 0.58 | |||||
5-Year Yield-on-Cost % | 0.58 | |||||
3-Year Average Share Buyback Ratio | -7.6 | |||||
Shareholder Yield % | 8.1 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.95 | |||||
Operating Margin % | 3.95 | |||||
Net Margin % | 2.95 | |||||
FCF Margin % | 2.64 | |||||
ROE % | 4.31 | |||||
ROA % | 2.57 | |||||
ROIC % | 4.27 | |||||
ROC (Joel Greenblatt) % | 5.19 | |||||
ROCE % | 5.84 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.87 | |||||
PE Ratio without NRI | 18.44 | |||||
PS Ratio | 0.54 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.74 | |||||
Price-to-Free-Cash-Flow | 21.35 | |||||
Price-to-Operating-Cash-Flow | 5.83 | |||||
EV-to-EBIT | 14.82 | |||||
EV-to-EBITDA | 7.35 | |||||
EV-to-Revenue | 0.62 | |||||
EV-to-FCF | 23.56 | |||||
Price-to-Graham-Number | 0.78 | |||||
Price-to-Net-Current-Asset-Value | 18.25 | |||||
Earnings Yield (Greenblatt) % | 6.75 | |||||
FCF Yield % | 5.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
RP Bio lnc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 148,030.362 | ||
EPS (TTM) (â‚©) | 459 | ||
Beta | 0 | ||
Volatility % | 25.1 | ||
14-Day RSI | 32.55 | ||
14-Day ATR (â‚©) | 235.990281 | ||
20-Day SMA (â‚©) | 9105 | ||
12-1 Month Momentum % | -17.15 | ||
52-Week Range (â‚©) | 7190 - 12400 | ||
Shares Outstanding (Mil) | 8.65 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RP Bio lnc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RP Bio lnc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
RP Bio lnc Frequently Asked Questions
What is RP Bio lnc(XKRX:314140)'s stock price today?
When is next earnings date of RP Bio lnc(XKRX:314140)?
Does RP Bio lnc(XKRX:314140) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |